The Jak2 Inhibitor, G6, Alleviates Jak2-V617F–Mediated Myeloproliferative Neoplasia by Providing Significant Therapeutic Efficacy to the Bone Marrow
Titel:
The Jak2 Inhibitor, G6, Alleviates Jak2-V617F–Mediated Myeloproliferative Neoplasia by Providing Significant Therapeutic Efficacy to the Bone Marrow
Auteur:
Kirabo, Annet Park, Sung O. Majumder, Anurima Gali, Meghanath Reinhard, Mary K. Wamsley, Heather L. Zhao, Zhizhuang Joe Cogle, Christopher R. Bisht, Kirpal S. Keserű, György M. Sayeski, Peter P.